Startseite Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children

  • Victor Lin , Tyler Hamby ORCID logo , Siddharth Das , Amritpaul Chatrath , Riyaz Basha , Kimberly G. Fulda und Nusrath Habiba
Veröffentlicht/Copyright: 6. April 2021

Abstract

Objectives

Given their established role in hepatic function and insulin resistance for adults, early screening of type 2 diabetes mellitus (T2DM) in the pediatric population may potentially be improved by the assessment of elevated liver enzymes.

Methods

Our study enrolled 151 nondiabetic children aged 10–14 years. Patients were assessed for demographics and five risk factors for T2DM. The levels of γ-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) levels were determined in serum samples. The effects of demographics and risk factors on abnormal liver enzyme levels were assessed with univariate chi-square analyses and also with multivariate logistic regression analyses, which were controlled for gender.

Results

Frequencies for abnormal liver enzyme values were as follows: 13 (9%) for GGT, 5 (3%) for ALT, and 20 (13%) for ALP. Across analyses, two results were consistently statistically significant. Females were more likely to have abnormal ALP levels, and patients with BMI percentile ≥95% and with acanthosis nigricans were more likely to have abnormal GGT levels.

Conclusions

Our study suggests GGT as potential marker for T2DM discovery in children. Subsequent long-term longitudinal studies would help to more clearly delineate GGT’s association with T2DM. Additionally, future studies that elucidate the molecular contribution of GGT elevation to T2DM pathogenesis are needed.


Corresponding author: Nusrath Habiba, MD, Associate Professor, Department of Pediatrics, Texas College of Osteopathic Medicine, University of North Texas Health Science Center, 855 Montgomery St. # 183, Fort Worth, TX76107, USA, E-mail:

Acknowledgments

This study was conducted as part of the University of North Texas Health Science Center and Cook Children’s Pediatric Research Program (PRP).

  1. Research funding: None declared.

  2. Author contributions: Victor Lin assisted with interpretation of data and drafting the manuscript. Tyler Hamby assisted with interpretation of data, statistical analysis of data, and drafting the manuscript. Siddharth Das assisted with drafting the manuscript. Amritpaul Chatrath assisted with drafting the manuscript. Riyaz Basha assisted with interpretation of data, and drafting the manuscript. Kimberly G. Fulda assisted with acquisition of data and drafting the manuscript. Nusrath Habiba assisted with acquisition of data, interpretation of data, and drafting the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The funding organization(s) (none declared) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Ethical approval: All study procedures were approved by the UNTHSC Institutional Review Board. Data were collected prospectively as part of a larger study [5]. A consent form was signed prior to enrollment, and a questionnaire was completed regarding demographic information.

  5. Employment or leadership: None declared.

  6. Honorarium: None declared.

References

1. Ward, ZJ, Long, MW, Resch, SC, Giles, CM, Cradock, AL, Gortmaker, SL. Simulation of growth trajectories of childhood obesity into adulthood. N Engl J Med 2017;377:2145–53. https://doi.org/10.1056/nejmoa1703860.Suche in Google Scholar PubMed PubMed Central

2. Younossi, ZM, Koenig, AB, Abdelatif, D, Fazel, Y, Henry, L, Wymer, M. Global epidemiology of nonalcoholic fatty liver disease--meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73–84. https://doi.org/10.1002/hep.28431.Suche in Google Scholar PubMed

3. Sherif, ZA, Saeed, A, Ghavimi, S, Nouraie, SM, Laiyemo, AO, Brim, H, et al.. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig Dis Sci 2016;61:1214–25. https://doi.org/10.1007/s10620-016-4143-0.Suche in Google Scholar PubMed PubMed Central

4. Cho, NH, Jang, HC, Choi, SH, Kim, HR, Lee, HK, Chan, JC, et al.. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care 2007;30:2566–8.https://doi.org/10.2337/dc07-0106.Suche in Google Scholar PubMed

5. Habiba, NM, Fulda, KG, Basha, R, Shah, D, Fernando, S, Nguyen, B, et al.. Correlation of lipid profile and risk of developing type 2 diabetes mellitus in 10–14 year old children. Cell Physiol Biochem 2016;39:1695–704. https://doi.org/10.1159/000447870.Suche in Google Scholar PubMed

6. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 2020;43:S14–31. https://doi.org/10.2337/dc20-s002.Suche in Google Scholar PubMed

7. Grossman, DC, Bibbins-Domingo, K, Curry, SJ, Barry, MJ, Davidson, KW, Doubeni, CA, et al.. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. J Am Med Assoc 2017;317:2417–26.10.1001/jama.2017.6803Suche in Google Scholar PubMed

8. Vos, MB, Abrams, SH, Barlow, SE, Caprio, S, Daniels, SR, Kohli, R, et al.. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319–34. https://doi.org/10.1097/mpg.0000000000001482.Suche in Google Scholar

9. Mora, S, Pitukcheewanont, P, Kaufman, FR, Nelson, JC, Gilsanz, V. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 1999;14:1664–71. https://doi.org/10.1359/jbmr.1999.14.10.1664.Suche in Google Scholar PubMed

10. Fernandez-Gaxiola, AC, Valdes-Ramos, R, Fulda, KG, Lopez, ALG, Martinez-Carrillo, BE, Franks, SF, et al.. Liver biomarkers and lipid profiles in Mexican and Mexican-American 10- to 14-year-old adolescents at risk for type 2 diabetes. J Diabetes Res 2017;2017:4262536. https://doi.org/10.1155/2017/4262536.Suche in Google Scholar PubMed PubMed Central

11. Nakanishi, N, Nishina, K, Li, W, Sato, M, Suzuki, K, Tatara, K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003;254:287–95. https://doi.org/10.1046/j.1365-2796.2003.01198.x.Suche in Google Scholar PubMed

12. Kunutsor, SK, Abbasi, A, Adler, AI. Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis. Ann Epidemiol 2014;24:809–16. https://doi.org/10.1016/j.annepidem.2014.09.001.Suche in Google Scholar PubMed

13. Koenig, G, Seneff, S. Gamma-glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk. Dis Markers 2015;2015:818570. https://doi.org/10.1155/2015/818570.Suche in Google Scholar PubMed PubMed Central

14. Lee, SY, Sung, E, Chang, Y. Elevated serum gamma-glutamyltransferase is a strong marker of insulin resistance in obese children. Int J Endocrinol 2013;2013:578693. https://doi.org/10.1155/2013/578693.Suche in Google Scholar PubMed PubMed Central

15. Wang, H, Li, L, Zhang, S. Non-linear relationship between gamma-glutamyl transferase and type 2 diabetes mellitus risk: secondary analysis of a prospective cohort study. J Int Med Res 2020;48. https://doi.org/10.1177/0300060520937911.Suche in Google Scholar PubMed PubMed Central

Received: 2020-09-04
Accepted: 2021-02-22
Published Online: 2021-04-06
Published in Print: 2021-06-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Provocative growth hormone testing in children: how did we get here and where do we go now?
  4. Original Articles
  5. Mental and somatic health in university students with type 1 diabetes: new results from DiaSHoT18, a cross sectional national health and well-being survey
  6. Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children
  7. What is the relationship between obesity and new circadian rhythm parameters in Turkish children and adolescents? A case-control study
  8. Body fat distribution in trunk and legs are associated with cardiometabolic risk clustering among Chinese adolescents aged 10–18 years old
  9. Is overweight/obesity a risk factor for atopic allergic disease in prepubertal children? A case–control study
  10. Importance of individualizing treatment decisions in girls with central precocious puberty when initiating treatment after age 7 years or continuing beyond a chronological age of 10 years or a bone age of 12 years
  11. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study
  12. Levels of physical activity and barriers to sport participation in young people with gender dysphoria
  13. Serum sclerostin concentration is associated with specific adipose, muscle and bone tissue markers in lean adolescent females with increased physical activity
  14. Validation of a continuous measure of cardiometabolic risk among adolescents
  15. Clinical characteristics and molecular genetic analysis of a cohort with idiopathic congenital hypogonadism
  16. The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A
  17. Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets
  18. Case Reports
  19. Asymptomatic pituitary apoplexy induced by corticotropin-releasing hormone in a 14 year-old girl with Cushing’s disease
  20. Two patients from Turkey with a novel variant in the GM2A gene and review of the literature
  21. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate
  22. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess
Heruntergeladen am 13.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0512/html
Button zum nach oben scrollen